Status:
COMPLETED
The Effect of Amniotic Membrane Injection as An Addition to Physical Therapy in Patients With Rotator Cuff Tear
Lead Sponsor:
Shin Kong Wu Ho-Su Memorial Hospital
Conditions:
Rotator Cuff Tear
Rotator Cuff Tendinopathy
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Rotator cuff tear (RCT) is a commonly seen pathology in shoulder disease, which causes significant disability in daily living and work. Based on a cohort study of a large population, the prevalence of...
Detailed Description
Rotator cuff tear (RCT) is a commonly seen pathology in shoulder disease, which causes significant disability in daily living and work. Based on a cohort study of a large population, the prevalence of...
Eligibility Criteria
Inclusion
- . symptomatic rotator cuff tendinopathy, including partial-thickness tear or small (\<1cm) full-thickness tear, proven by ultrasound
- . duration of symptom longer than 1 month
- . age ≥20 years old
Exclusion
- .fracture, dislocation, or arthritis of the shoulder
- . previous shoulder joint surgery
- . rotator cuff full-thickness tear with size ≥ 1cm
- . calcification of rotator cuff tendons
- . severe medical comorbidities, e.g., malignant neoplasms, blood dyscrasia, and serious infection, etc.
- . pregnancy
- . cognitive impairment (Mini-Mental Status Examination \< 24).
Key Trial Info
Start Date :
March 29 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 12 2024
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT05320419
Start Date
March 29 2023
End Date
April 12 2024
Last Update
April 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shin Kong Wu Ho-Su Memorial Hospital
Taipei, Taiwan